AU3122189A - Combinations of polysulfated heparins in the treatment of retrovirus infections - Google Patents

Combinations of polysulfated heparins in the treatment of retrovirus infections

Info

Publication number
AU3122189A
AU3122189A AU31221/89A AU3122189A AU3122189A AU 3122189 A AU3122189 A AU 3122189A AU 31221/89 A AU31221/89 A AU 31221/89A AU 3122189 A AU3122189 A AU 3122189A AU 3122189 A AU3122189 A AU 3122189A
Authority
AU
Australia
Prior art keywords
combinations
treatment
retrovirus infections
polysulfated
heparins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31221/89A
Inventor
Lothar Daum
Thomas Doerper
Karl-Heinz Geiss
Dieter Herr
Erich Schlick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU3122189A publication Critical patent/AU3122189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31221/89A 1988-03-12 1989-03-10 Combinations of polysulfated heparins in the treatment of retrovirus infections Abandoned AU3122189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3808353 1988-03-12
DE3808353A DE3808353A1 (en) 1988-03-12 1988-03-12 COMBINATIONS OF POLYSULFATED HEPARINES IN THE FIGHT AGAINST RETROVIRUS INFECTIONS

Publications (1)

Publication Number Publication Date
AU3122189A true AU3122189A (en) 1989-09-14

Family

ID=6349622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31221/89A Abandoned AU3122189A (en) 1988-03-12 1989-03-10 Combinations of polysulfated heparins in the treatment of retrovirus infections

Country Status (4)

Country Link
EP (1) EP0332952A3 (en)
JP (1) JPH01275532A (en)
AU (1) AU3122189A (en)
DE (1) DE3808353A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE130516T1 (en) * 1989-02-10 1995-12-15 Taiho Pharmaceutical Co Ltd ANTI-HIV REMEDIES.
GB9020872D0 (en) * 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions and use thereof
WO1993001825A1 (en) * 1991-07-19 1993-02-04 Otsuka Pharmaceutical Co., Ltd. Antitumor drug
FR2838649B1 (en) 2002-04-19 2006-01-13 Commissariat Energie Atomique ANTI-HIV COMPOSITION, METHOD OF MANUFACTURE AND MEDICINAL PRODUCT
EP1547469A1 (en) 2003-12-22 2005-06-29 Nestec S.A. Depositing device
EP2497523B1 (en) 2005-03-07 2016-11-16 Erskine Medical LLC Catheter introducer with needle shield
JP5273461B2 (en) 2006-11-17 2013-08-28 国立大学法人 長崎大学 Retrovirus infection inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions

Also Published As

Publication number Publication date
DE3808353A1 (en) 1989-09-21
EP0332952A3 (en) 1990-08-29
EP0332952A2 (en) 1989-09-20
JPH01275532A (en) 1989-11-06

Similar Documents

Publication Publication Date Title
AU7865187A (en) Parallel processing
AU4352889A (en) Improvements in the production of coated components
AU4249589A (en) Non-invasive inspection
AU588670B2 (en) Improvements in the manufacture of curved glass
AU3731489A (en) Pulp treatment methods
AU7332987A (en) Sulfated polysaccharide
AU6423590A (en) The treatment of wood chips
AU580913B2 (en) Treating laminates
AU591382B2 (en) Reinforced cellulose aminomethanate
AU3122189A (en) Combinations of polysulfated heparins in the treatment of retrovirus infections
AU1758788A (en) Composites
AU8269787A (en) Flyslag treatment
AU591263B2 (en) Anti-allergic agent
AU3316289A (en) Water treatment
AU574606B1 (en) 1,5-diphenyl-1h-1,2,4-triazole-3-carboxamide derivatives
AU4019489A (en) Surface treatment
AU2135988A (en) Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure
AU7976587A (en) Aminoglycoside phosphotransferase-proteinfusions
AU8084587A (en) Improvements relating to bathythermographs or the like
AU5630990A (en) Utilisation of acridine derivatives in the treatment of retroviral infections in humans
AU1815888A (en) Energetic azido curing agents
AU4603289A (en) Novel treatment
AU4102789A (en) Treatment compositions
AU7388087A (en) Novel hepta and/or octa-peptides
AU2080888A (en) Shellfisch processing